Close Menu
    Trending
    • Guinea ends mpox outbreak more than two years after first case
    • WFP warns funding gaps will leave millions hungry in 2027
    • South Korea’s exports pass $1 trillion for the first time
    • American Businessman Mark Eric Williams Vindicated in Six-Year, US$150 Million-Plus Litigation Brought by Kuwaiti State Entities
    • Air Arabia Egypt launches Cairo to Al Ain flights soon
    • TÜV SÜD opens its International Technology & Innovation Campus in the Guangdong-Hong Kong-Macao Greater Bay Area
    • Huawei Unveils Financial AI Scaling Capabilities at Singapore FinTech Festival 2026
    • Botswana opens consultations on proposed 33 percent hike now
    Saturday, November 21
    UAE TribuneUAE Tribune
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    UAE TribuneUAE Tribune
    Home » FDA flags child-friendly 7-OH kratom products as risky trend
    Health

    FDA flags child-friendly 7-OH kratom products as risky trend

    July 30, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    The U.S. Food and Drug Administration (FDA) is calling for tighter federal control over 7-hydroxymitragynine (7-OH), a potent psychoactive compound derived from the kratom plant, citing its high potential for abuse and opioid-like effects. The agency has formally recommended classifying 7-OH as a Schedule I controlled substance, aligning it with drugs such as heroin and cocaine under the Controlled Substances Act.

    The move follows a surge in the popularity of 7-OH products sold in vape shops, gas stations, and online retailers. While kratom in its natural form has long been used as a stimulant or pain reliever, 7-OH appears in much higher concentrations in processed products such as tablets, gummies, drink powders, and oral shots.

    These products are often marketed without regulatory approval, and some are packaged in formats like fruit-flavored edibles that may appeal to children, prompting further concern among health authorities. FDA Commissioner Dr. Marty Makary stated that 7-OH binds to the brain’s opioid receptors, potentially triggering respiratory depression, physical dependence, and withdrawal symptoms similar to those caused by prescription opioids.

    Growing public health concerns over synthetic kratom derivatives

    The compound has been shown to be more potent than morphine in animal models, raising alarms over its uncontrolled availability. The FDA emphasized that it has not approved any drug or dietary supplement containing kratom, 7-OH, or mitragynine, the plant’s other primary alkaloid.

    Health and Human Services Secretary Robert F. Kennedy Jr. called the recommendation part of a broader strategy to reduce opioid misuse. “We’re taking action on 7-OH as a critical step in the fight against opioid addiction,” Kennedy said during a press briefing. He underscored the need to prevent unregulated psychoactive compounds from contributing to another addiction crisis, particularly among youth.

    The FDA’s recommendation follows an earlier enforcement effort in which it issued warning letters to seven companies for the illegal marketing of 7-OH products. These companies were cited for distributing unapproved drug products, which the agency determined were neither safe nor effective for any medical use.

    Under current law, the Drug Enforcement Administration (DEA) will review the FDA’s request and conduct its own scheduling process, which includes rulemaking and public comment. According to the Legislative Analysis and Public Policy Association, kratom’s legal status varies by state.

    FDA cites urgent need for public education and regulation

    As of March 2025, seven states and the District of Columbia classify kratom as a controlled substance, while 18 others regulate its sale or possession. The remaining 26 states do not have specific restrictions. The FDA clarified that its latest action targets 7-OH specifically and does not apply to kratom leaf products in general, though those too have been linked to adverse outcomes, including fatalities.

    Researchers continue to study 7-OH’s health effects and potential risks. Dr. Kirsten Elin Smith of Johns Hopkins University, who is surveying users of the compound, noted that while some individuals report benefits such as pain relief or mood improvement, others experience strong addictive effects.

    Smith said more scientific data is necessary to fully understand the substance’s safety profile. The FDA warns that consumers using 7-OH products are exposed to substances with no proven safety or therapeutic value. As the agency advances its regulatory actions, it aims to close the gap between rapid market proliferation and public health oversight. – By Content Syndication Services.

    Related Posts

    Guinea ends mpox outbreak more than two years after first case

    November 21, 2026

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Yellow fever kills 18 across nine African nations, WHO says

    November 7, 2026

    Dengue kills 173 in October as Bangladesh toll climbs to 418

    November 2, 2026

    Ebola death toll in DR Congo nears 4,900 as cases pass 10,000

    October 28, 2026
    Latest News

    Guinea ends mpox outbreak more than two years after first case

    November 21, 2026

    WFP warns funding gaps will leave millions hungry in 2027

    November 21, 2026

    South Korea’s exports pass $1 trillion for the first time

    November 21, 2026

    Air Arabia Egypt launches Cairo to Al Ain flights soon

    November 20, 2026

    Botswana opens consultations on proposed 33 percent hike now

    November 19, 2026

    PM Modi meets Prince and Princess of Wales for climate talks

    November 19, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Dubai Airports expects over 70 million guests in 2026

    November 18, 2026
    © 2026 UAE Tribune | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.